To study the efficacy of Dhanyaka-gokshuradi ghrita in comparison with Tamsulosin hydrochloride for the treatment of benign enlargement of prostate
Phase 2
Completed
- Conditions
- Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
- Registration Number
- CTRI/2020/12/029728
- Lead Sponsor
- Dr Sayali Babasaheb Gore
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
•A known diagnosed case of (benign enlargement of prostate) on the basis of clinical and investigative methods.
•Male patient of age group more than 40 -60 yrs. Irrespective of religion and occupation.
•Prostate size below 35 gms
Exclusion Criteria
• Acute/chronic retention of urine, stone formation, renal failure.
•Bladder neck stenosis, bladder diverticulum, neurogenic bladder, neoplasm of bladder, urethral stricture.
•CA prostate, Prostitis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1)Benign enlargement of prostate is one of the most common diseases in ageing men and most common cause of lower urinary tract symptoms_ <br/ ><br>The prevalence of BEP increases after the age of 40 years. Genetics, diet and life style also Contributes for BEP. <br/ ><br>2)To evaluate the and establish safer,cost-effective Dhanyaka-gokshuradi ghrita in the management of benign enlargement of prostate-[management of benign enlargement of prostate]Timepoint: Duration of treatment 21days total
- Secondary Outcome Measures
Name Time Method Dhanyaka-gokshuradi ghrita is effective the management of benign enlargement of prostate-[management of benign enlargement of prostate]Timepoint: 21 days study with 4 follow up <br/ ><br>(0,7,14,21 days) <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br>